Literature DB >> 9454836

Interaction of huntingtin-associated protein with dynactin P150Glued.

S H Li1, C A Gutekunst, S M Hersch, X J Li.   

Abstract

Huntingtin is the protein product of the gene for Huntington's disease (HD) and carries a polyglutamine repeat that is expanded in HD (>36 units). Huntingtin-associated protein (HAP1) is a neuronal protein and binds to huntingtin in association with the polyglutamine repeat. Like huntingtin, HAP1 has been found to be a cytoplasmic protein associated with membranous organelles, suggesting the existence of a protein complex including HAP1, huntingtin, and other proteins. Using the yeast two-hybrid system, we found that HAP1 also binds to dynactin P150(Glued) (P150), an accessory protein for cytoplasmic dynein that participates in microtubule-dependent retrograde transport of membranous organelles. An in vitro binding assay showed that both huntingtin and P150 selectively bound to a glutathione transferase (GST)-HAP1 fusion protein. An immunoprecipitation assay demonstrated that P150 and huntingtin coprecipitated with HAP1 from rat brain cytosol. Western blot analysis revealed that HAP1 was enriched in rat brain microtubules and comigrated with P150 and huntingtin in sucrose gradients. Immunofluorescence showed that transfected HAP1 colocalized with P150 and huntingtin in human embryonic kidney (HEK) 293 cells. We propose that HAP1, P150, and huntingtin are present in a protein complex that may participate in dynein-dynactin-associated intracellular transport.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454836      PMCID: PMC6792727     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Predicting coiled coils from protein sequences.

Authors:  A Lupas; M Van Dyke; J Stock
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

Review 2.  When more is less: pathogenesis of glutamine repeat neurodegenerative diseases.

Authors:  C A Ross
Journal:  Neuron       Date:  1995-09       Impact factor: 17.173

3.  Retrograde transport by the microtubule-associated protein MAP 1C.

Authors:  B M Paschal; R B Vallee
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

4.  Expression of normal and mutant huntingtin in the developing brain.

Authors:  P G Bhide; M Day; E Sapp; C Schwarz; A Sheth; J Kim; A B Young; J Penney; J Golden; N Aronin; M DiFiglia
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

5.  A novel brain ATPase with properties expected for the fast axonal transport motor.

Authors:  S T Brady
Journal:  Nature       Date:  1985 Sep 5-11       Impact factor: 49.962

6.  Cytoplasmic dynein binds dynactin through a direct interaction between the intermediate chains and p150Glued.

Authors:  K T Vaughan; R B Vallee
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

7.  Kinesin associates with anterogradely transported membranous organelles in vivo.

Authors:  N Hirokawa; R Sato-Yoshitake; N Kobayashi; K K Pfister; G S Bloom; S T Brady
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

8.  Cytoplasmic dynein participates in the centrosomal localization of the Golgi complex.

Authors:  I Corthésy-Theulaz; A Pauloin; S R Pfeffer
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

9.  Dynactin, a conserved, ubiquitously expressed component of an activator of vesicle motility mediated by cytoplasmic dynein.

Authors:  S R Gill; T A Schroer; I Szilak; E R Steuer; M P Sheetz; D W Cleveland
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

10.  Saccharomyces cerevisiae kinesin- and dynein-related proteins required for anaphase chromosome segregation.

Authors:  W S Saunders; D Koshland; D Eshel; I R Gibbons; M A Hoyt
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  99 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin.

Authors:  S H Li; A L Cheng; H Li; X J Li
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

3.  Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

Authors:  C A Gutekunst; S H Li; H Yi; J S Mulroy; S Kuemmerle; R Jones; D Rye; R J Ferrante; S M Hersch; X J Li
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

4.  Disrupted GABAAR trafficking and synaptic inhibition in a mouse model of Huntington's disease.

Authors:  Eunice Y Yuen; Jing Wei; Ping Zhong; Zhen Yan
Journal:  Neurobiol Dis       Date:  2012-02-28       Impact factor: 5.996

5.  Misfolded Gβ is recruited to cytoplasmic dynein by Nudel for efficient clearance.

Authors:  Yihan Wan; Zhenye Yang; Jing Guo; Qiangge Zhang; Liyong Zeng; Wei Song; Yue Xiao; Xueliang Zhu
Journal:  Cell Res       Date:  2012-03-20       Impact factor: 25.617

Review 6.  Control of cytoplasmic mRNA localization.

Authors:  Karen Shahbabian; Pascal Chartrand
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

7.  The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-κB from the synapse to the nucleus.

Authors:  Edoardo Marcora; Mary B Kennedy
Journal:  Hum Mol Genet       Date:  2010-08-25       Impact factor: 6.150

8.  HAP1 Is Required for Endocytosis and Signalling of BDNF and Its Receptors in Neurons.

Authors:  Yoon Lim; Linda Lin-Yan Wu; Si Chen; Ying Sun; Swarna Lekha Vijayaraj; Miao Yang; Larisa Bobrovskaya; Damien Keating; Xiao-Jiang Li; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

Review 9.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

10.  Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking.

Authors:  Martina Metzler; Bo Li; Lu Gan; John Georgiou; Claire-Anne Gutekunst; Yushan Wang; Enrique Torre; Rebecca S Devon; Rosemary Oh; Valerie Legendre-Guillemin; Mark Rich; Christine Alvarez; Marina Gertsenstein; Peter S McPherson; Andras Nagy; Yu Tian Wang; John C Roder; Lynn A Raymond; Michael R Hayden
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.